Ask Congress to Ensure Access to FDA-Approved Alzheimer’s Treatments
The Centers for Medicare & Medicaid Services (CMS) is blocking coverage of FDA-approved treatments targeting amyloid for Alzheimer’s. Join us in asking Congress to call on CMS to change this decision. Take action for those living with Alzheimer’s.
Alzheimer’s disease is one of the most critical public health issues in America. That’s why the Alzheimer’s Impact Movement (AIM), the Alzheimer’s Association and our advocates are unrelenting. We fight to support Alzheimer's and dementia research funding and advance bipartisan legislation that will have a positive and meaningful impact on people living with Alzheimer's and their caregivers today and in the future.
With the support of volunteer advocates and bipartisan congressional champions we’re making an impact. Help us persuade policymakers to make Alzheimer’s a national priority.
We advocate for the more than 6 million Americans living with Alzheimer’s, a progressive and fatal brain disease.
We’ve increased the federal investment in Alzheimer’s and dementia research funding more than seven-fold in the last decade.
More than 11 million Americans provide unpaid care for people living with Alzheimer’s or other dementias.
Each month, we’re featuring an advocate who engages with policymakers to ensure priorities that improve the lives of people impacted by Alzheimer’s and all other dementia remain top-of-mind in Congres...
Alzheimer’s Policy in the States
Across the nation AIM advocates are working to advance public policies to improve the lives of individuals and families impacted by Alzheimer’s and all other dementia. Learn about Alzheimer’s policies and advocacy in your state.